BioSpace News Archive

Akebia Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, granted eight newly-hired employees options to purchase an aggregate of 115,600 shares of Akebia’s common stock on March 31, 2020, as inducements material to each such employee’s entering into employment with Akebia.

Sai Life Sciences, one of India’s fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced its induction into the Pharmaceutical Supply Chain Initiative (PSCI) membership as an ‘Associate Member’.

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company’s CEO Dr. Stuart Titus was featured in global financial news outlet U.S. News and World Report discussing his expertise in penny stocks.

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a pre-revenue development stage biopharmaceutical company focused on the development of immunology based therapies to treat prevalent inflammatory conditions announced today that it was featured on a FOX segment titled, " Englewood pharmaceutical company looking to treat COVID

Accelerated Enrollment Solutions ( AES ), a business of PPD, Inc. (Nasdaq: PPD ), and Science 37 , a leader in virtual clinical trials, are collaborating to recruit and enroll clinical trial participants who live beyond the geographic location of tr

John Wiley and Sons Inc. (NYSE:JWA) (NYSE:JWB), a global leader in research and education, today announced the acquisition of Bio-Rad Laboratories, Inc.’s Informatics products including the company’s spectroscopy software and spectral databases.

In collaboration, AMRA Medical and Fulcrum Therapeutics created a standardized whole-body magnetic resonance imaging (MRI) protocol to evaluate skeletal muscle composition in patients with facioscapulohumeral dystrophy (FSHD) – a slowly progressing muscular dystrophy

UCB today announced that the acquisition of Ra Pharmaceuticals, Inc. has been successfully completed and Ra Pharma is now a wholly-owned subsidiary of UCB.

MJH Life Sciences™ has announced it has acquired the Pharmacy Benefit Management Institute (PBMI) from Pharmaceutical Strategies Group (PSG).

BlueWillow Biologics®, a clinical-stage biopharmaceutical company, today announced the company will advance the manufacturing and commercialization of NanoBio® Protect, a nasal antiseptic solution that can be used to help reduce germs that could cause infections.